Revecore, which serves about 1,200 hospitals across the U.S., provides revenue integrity and complex claims solutions, according to an April 5 news release.
The acquisition will allow Revecore to build on its market leadership and invest in more technology, according to the release. Financial terms of the deal were not disclosed.
Existing investor Riverside Partners maintains a minority stake in Revecore.
The organizations also named former TransUnion Healthcare CEO Dave Wojczynski as CEO of Revecore.
“Our vision is to continue investing in current service areas while adding complementary adjacent service lines that will deliver additional value to existing and new customers,” Mr. Wojczynski said in the news release.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
